Skip to search formSkip to main contentSkip to account menu

emiglitate

Known as: N-(beta-(4-ethoxycarbonyl)phenoxy)ethyl-1-desoxy-nojirimycin, N-(beta-(4-ethoxycarbonyl)phenoxy)ethyl-1-desoxynojirimycin 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

1-DeoxynojirimycinAnti-Bacterial Agents
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1993
1993
The α-glucosidehydrolase inhibitor emiglitate induces differential effects on insulin release elicited by glucose and cholinergic stimulation
1987
1987
The clinical efficacy of a second-generation alpha-glucosidase inhibitor in non-insulin-dependent diabetic patients.
In a placebo-controlled double-blind randomised group comparison, the tolerability and metabolic effect of emiglitate, a new…